Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2022-08-09 00:00:00 ET · period of report 2022-08-05 · accession 0001567619-22-015307 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-09 | 2022-08-05 | PCSA | Stanker James H | CFO | F - Tax | $3.17 | -2,462 | 49.2K | -5% | -$7,805 | |
| 2022-08-09 | 2022-08-05 | PCSA | Stanker James H | CFO | M - OptEx | — | +7,601 | 51.7K | +17% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-05 | F | D | 2,462 | $3.17 | 49,250 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-05 | M | A | 7,601 | — | 51,712 | D | — | — | (F1) Vesting of time-based restricted shares. |